GGrantIndex
Sort

16,300 grants matching fatty liver disease

Evaluation of MRI & MR Spectroscopic Markers in Non-Alcoholic Fatty Liver Disease

$217,273
Aliya Qayyum · University Of California, San Francisco · R01 · FY2010 · DK

Evaluation of MRI & MR Spectroscopic Markers in Non-Alcoholic Fatty Liver Disease

$217,273
Aliya Qayyum · University Of California, San Francisco · R01 · FY2008 · DK

Chemoprevention of HCC related to MAFLD

$216,964
Fasiha Kanwal · Baylor College Of Medicine · P01 · FY2024 · CA

Clincal Research Network in Non-Alcoholic Steatohepatitis (NASH CRN)

$216,888
Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · DK

Mechanisms of Pro-Resolving Mediators in Periodontal Regeneration

$216,722
Thomas E Van Dyke · Ada Forsyth Institute, Inc. · R01 · FY2023 · DE

Longitudinal Change in Obesity during Childhood and Adult Cardiometabolic Risk

$216,474
Shengxu Li · Tulane University Of Louisiana · P20 · FY2020 · GM

Longitudinal Change in Obesity during Childhood and Adult Cardiometabolic Risk

$216,474
Shengxu Li · Tulane University Of Louisiana · P20 · FY2019 · GM

Modulation of micro-RNA and inflammation by Andrographolide in NAFLD pathology

$216,467
Saurabh Chatterjee · University Of South Carolina At Columbia · P20 · FY2019 · GM

Hepatocyte Exosomes for Therapy of Ethanol-Induced Liver Injury

$216,344
David R Brigstock · Research Inst Nationwide Children'S Hosp · R21 · FY2017 · AA

Metabolic effects of non-nutritive sweeteners

$216,254
Kristina Rother · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Targeting GDF15-GFRAL signaling in mitochondrial myopathies

$216,113
Marilena D'aurelio · Weill Medical Coll Of Cornell Univ · R21 · FY2025 · AR

Project 3: Developmental programming-aging interactions in primate metabolism

$215,828
Laura A Cox · University Of Wyoming · U19 · FY2019 · AG

Translational Core

$215,722
Teresa L. Wright · Rockefeller University · U19 · FY2007 · AI

Dietary Fat in Ethanol-Induced Intestinal Barrier Dysfunction in ALD

$215,625
Irina A. Kirpich · University Of Louisville · R21 · FY2012 · AA

The role of hepatocyte cAMP/PDE4 in alcohol-induced liver steatosis and injury

$215,625
Leila Gobejishvili · University Of Louisville · R21 · FY2014 · AA

FGF21 and adipose lipolysis in alcoholic fatty liver

$215,625
Wenke Feng · University Of Louisville · R21 · FY2014 · AA

Project 3 - Ming Song

$215,611
Ming Song · University Of Louisville · P20 · FY2022 · GM

Palmitoleate Protects against Cholangiocyte Lipoapoptosis

$215,552
Justin L. Mott · University Of Nebraska Lincoln · P20 · FY2015 · GM

MPS Resources Section

$215,550
Lawrence A Vernetti · University Of Pittsburgh At Pittsburgh · U2C · FY2025 · TR

Clinical Research Network in Nonalcoholic Steatohepatitis

$215,503
Kris Kowdley · Liver Institute Northwest Pllc · U01 · FY2023 · DK

Regulation of Gene Expression by Dietary Fat

$215,397
Lisa M Salati · West Virginia University · R01 · FY2006 · DK

Administrative Core

$215,388
Alan R. Shuldiner · University Of Maryland Baltimore · P30 · FY2010 · DK

ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer

$215,325
Gail E Sonenshein · Tufts University Boston · R21 · FY2016 · CA

Novel animal models to study miRNA-mediated alcoholic liver disease

$215,302
Suthat Liangpunsakul · Indiana University Indianapolis · UH2 · FY2019 · AA

Mechanisms of lipid droplet trafficking in hepatocellular carcinoma

$215,284
Micah Schott · University Of Nebraska Medical Center · R21 · FY2023 · CA